Calliditas Therapeutics
Calliditas: Potential secondary listing in the US (Redeye)
2020-01-10 11:51
Yesterday, Calliditas announced that it has submitted a draft registration statement relating to a potential U.S. IPO of ADSs (American Depositary Shares) on the Nasdaq Stock Market. We provide a brief comment on the news.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se